Aa
A
A
Close
1569985 tn?1328251082
FDA Alert for Cardiac drug
New FDA Medwatch Alert
Sent to subscribers of: olmesartan systemic, olmesartan
Drug Safety Communication: Olmesartan Medoxomil - Label Changes To Include Intestinal Problems (Sprue-Like Enteropathy)
July 3, 2013
Audience: Health Professional, Cardiology, Patient.
ISSUE: FDA is warning that the blood pressure drug Olmesartan Medoxomil (marketed as Benicar, Benicar HCT, Azor, Tribenzor, and generics) can cause intestinal problems known as sprue-like enteropathy. Symptoms of sprue-like enteropathy include severe, chronic diarrhea with substantial weight loss. FDA has approved changes to the labels of these drugs to include this concern. Sprue-like enteropathy has not been detected with ARB drugs other than olmesartan. Read more.
More FDA Medwatch Alerts...
Cancel
0 Answers
Page 1 of 1
Your Answer
Avatar universal
Answer
Do you know how to answer? Tap here to leave your answer...
Answer
Answer
Post Answer
A
A
Top Arrhythmias Answerers
1807132 tn?1318747197
Blank
MichelleP_3811
Chicago, IL
995271 tn?1463927859
Blank
itdood
PA
1423357 tn?1414258965
Blank
tom_h
Central, MA
Avatar f tn
Blank
CFS56
12492606 tn?1459877633
Blank
researcher09
CA
Avatar f tn
Blank
kaylamt
Recent Activity
Avatar universal
Blank
tacolino is ... Comment
5 hrs ago
506791 tn?1439846583
Blank
Piparskeggr commented on photo
6 hrs ago
242912 tn?1402547092
Blank
Jade59 commented on photo
6 hrs ago
Heart Rhythm Community Resources
Top Arrhythmias Answerers
1807132 tn?1318747197
Blank
MichelleP_3811
Chicago, IL
995271 tn?1463927859
Blank
itdood
PA
1423357 tn?1414258965
Blank
tom_h
Central, MA
Avatar f tn
Blank
CFS56
12492606 tn?1459877633
Blank
researcher09
CA
Avatar f tn
Blank
kaylamt